Published in Ann Rheum Dis on March 01, 1973
Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J (1981) 1.53
[Conservative local therapy of inflammation of joints: local invasive forms of therapy]. Z Rheumatol (2007) 1.42
Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis (1985) 1.41
Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models. Arthritis Res Ther (2016) 1.39
Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J (1988) 1.25
Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis (1985) 1.20
Effect of intra-articular hyaluronan on pressure-flow relation across synovium in anaesthetized rabbits. J Physiol (1995) 1.13
Lysosomal activation by neutral saccharides in cell cultures of synovium. Ann Rheum Dis (1977) 1.04
Evaluation of serum chondroitin sulfate and hyaluronan: biomarkers for osteoarthritis in canine hip dysplasia. J Vet Sci (2008) 0.83
Hyaluronate in rheumatology and orthopaedics: is there a role? Ann Rheum Dis (1990) 0.80
The biophysical mechanisms of altered hyaluronan concentration in synovial fluid after anterior cruciate ligament transection. Arthritis Rheum (2012) 0.79
[Human joint capsule in osteoarthrosis (morpholocical changes) (author's transl)]. Arch Orthop Unfallchir (1977) 0.75
A randomised, double-blinded, placebo-controlled clinical study on intra-articular hyaluronan treatment in equine lameness originating from the metacarpophalangeal joint. BMC Vet Res (2016) 0.75
Sulphate (35SO4) uptake by chondrocytes in relation to histological changes in osteoarthritic human articular cartilage. Ann Rheum Dis (1960) 4.56
The permeability of articular cartilage. J Bone Joint Surg Br (1968) 3.17
Isolation of chondroitin sulfate-S35 from articular cartilage of rats. J Biol Chem (1951) 2.62
Sulphate (35SO4) fixation by human articular cartilage compared in the knee and shoulder joints. Ann Rheum Dis (1961) 2.29
Synthesis of hyaluronic acid by human synovial tissue slices. Science (1957) 2.09
Mucopolysaccharides produced in tissue culture. J Biophys Biochem Cytol (1957) 2.01
THE PRESENCE OF HYALURONIDASE IN VARIOUS MAMMALIAN TISSUES. J Biol Chem (1963) 1.99
Studies on bone enzymes. The assay of acid hydrolases and other enzymes in bone tissue. Biochem J (1965) 1.88
The tissue content and turnover rates of intermediates in the biosynthesis of glycosaminoglycans in young rat skin. Biochem J (1968) 1.48
Mucopolysaccharides in tissue cultures of human and mammalian synovial membrane. Proc Soc Exp Biol Med (1955) 1.44
Amyloid deposits in articular cartilage. Ann Rheum Dis (1970) 1.30
The fate of injected mucopolysac-charides. J Clin Invest (1962) 0.98
Fractionation and recovery of secretions of synovial cells synthesized in culture with radioactive precursors. Ann Rheum Dis (1973) 0.93
Effect of the thyroid gland on metabolism of acid mucopolysaccharides in skin. Biochim Biophys Acta (1962) 0.92
[On the loss of tissue mucopolysaccharides during fixation]. Acta Histochem (1967) 0.81
Hyaluronan. FASEB J (1992) 6.67
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl (1994) 2.23
Ferritin in synovial cells in patients with rheumatoid arthritis. Ann Rheum Dis (1966) 2.21
The anaemia of rheumatoid arthritis: the significance of iron deposits in the synovial membrane. Australas Ann Med (1970) 1.88
The structure and function of hyaluronan: An overview. Immunol Cell Biol (1996) 1.84
Culture of synovial cells in vitro. Notes on isolation and propagation. Ann Rheum Dis (1965) 1.83
Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res (1983) 1.74
Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum (1987) 1.70
Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol Appl Neurobiol (2000) 1.64
On the pericellular zone of some mammalian cells in vitro. Exp Cell Res (1968) 1.63
Iron in the synovial membrane in rheumatoid arthritis and other joint diseases. Ann Rheum Dis (1968) 1.60
Do lymphocytes protect the rheumatoid joint? Br Med J (1971) 1.57
Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J (1981) 1.53
Concentration and relative molecular mass of hyaluronate in lymph and blood. Biochem J (1986) 1.50
Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J (1984) 1.50
Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. Community Oriented Programme for the Control of Rheumatic Disease. J Rheumatol (1998) 1.47
Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol (1991) 1.44
Rheumatic diseases in China. J Rheumatol (1994) 1.42
Change in serum hyaluronan: a simple index of short-term drug-induced changes in hepatic sinusoidal perfusion. Gastroenterology (1993) 1.41
Lysosomal enzymes in synovial membrane in rheumatoid arthritis. Relationship to joint damage. Ann Rheum Dis (1972) 1.39
Concentration of iron in synovial membrane, synovial fluid, and serum in rheumatoid arthritis and other joint diseases. Ann Rheum Dis (1968) 1.37
Binding of hyaluronate and chondroitin sulphate to liver endothelial cells. Biochem J (1986) 1.36
Epidemiology of rheumatic diseases in rural and urban populations in Indonesia: a World Health Organisation International League Against Rheumatism COPCORD study, stage I, phase 2. Ann Rheum Dis (1992) 1.34
Ferritin formation by synovial cells exposed to haemoglobin in vitro. Ann Rheum Dis (1967) 1.33
Elimination of hyaluronic acid from the blood stream in the human. Clin Exp Pharmacol Physiol (1984) 1.31
The properties and turnover of hyaluronan. Ciba Found Symp (1986) 1.26
Light and electron microscope studies in carragheenin, adjuvant, and tuberculin-induced arthris. Ann Rheum Dis (1969) 1.26
Functions of hyaluronan. Ann Rheum Dis (1995) 1.23
Rheumatoid synovial cells from intact joints. Morphology, growth, and polykaryocytosis. Ann Rheum Dis (1977) 1.20
Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ. Cell Tissue Res (1985) 1.16
What does ILAR do? International League Against Rheumatism. Br J Rheumatol (1990) 1.13
Absorption of hyaluronan applied to the surface of intact skin. J Invest Dermatol (1999) 1.13
Risk factors for osteoporosis and fracture in patients attending rheumatology outpatient clinics. Aust N Z J Med (1999) 1.10
Tissue uptake of circulating hyaluronic acid. A whole body autoradiographic study. Cell Tissue Res (1983) 1.10
Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice. Neuropathol Appl Neurobiol (2003) 1.09
Rheumatic pain in a Philippine village. A WHO-ILAR COPCORD Study. Rheumatol Int (1985) 1.09
On the reactions of human synovial cells exposed to homologous leucocytes in vitro. Clin Exp Immunol (1970) 1.06
The International League of Associations for Rheumatology and the information deficit. Br J Rheumatol (1993) 1.06
Cytology of synovial effusions in epidemic polyarthritis. Aust N Z J Med (1981) 1.05
In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies. Neuropathol Appl Neurobiol (1997) 1.05
Lysosomal activation by neutral saccharides in cell cultures of synovium. Ann Rheum Dis (1977) 1.04
The effects of homologous and heterologous whole serum upon multiplication of recently-isolated human synovial cells in culture. Aust J Exp Biol Med Sci (1967) 1.02
A comparison of the diseases caused by Ross River virus and Barmah Forest virus. Med J Aust (1998) 1.01
Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum (1990) 1.00
Effect of cell-bound hyaluronic acid on infectivity of Newcastle disease virus for human synovial cells in vitro. Ann Rheum Dis (1974) 0.99
Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain. Neuroscience (2002) 0.99
Pleurodesis: the results of treatment for spontaneous pneumothorax in the Royal Air Force. Aviat Space Environ Med (1983) 0.97
Patterns of induced variation in the morphology, hyaluronic acid secretion, and lysosomal enzyme activity of cultured human synovial cells. Ann Rheum Dis (1979) 0.97
Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. J Comp Pathol (2001) 0.96
Uncertainties in carbon dioxide radiative forcing in atmospheric general circulation models. Science (1993) 0.96
Chondrocyte-derived cells and matrix at the rheumatoid cartilage-pannus junction identified with monoclonal antibodies. Rheumatol Int (1987) 0.96
The epidemiology of gout and hyperuricemia in a rural population of Java. J Rheumatol (1992) 0.96
A survey of outcome measurement procedures in routine rheumatology outpatient practice in Australia. J Rheumatol (1999) 0.95
Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleeding. Med J Aust (1993) 0.95
Lymph node iron in rheumatoid arthritis. Histology, ultrastructure, and chemical concentration. Ann Rheum Dis (1970) 0.95
Leg ulcers in rheumatoid arthritis. Med J Aust (1990) 0.95
Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis. Arthritis Rheum (1999) 0.95
Epidemic polyarthritis and Ross River virus disease. Clin Rheum Dis (1986) 0.94
Determination of the frequency and distribution of vascular and parenchymal amyloid with polyclonal and N-terminal-specific PrP antibodies in scrapie-affected sheep and mice. Vet Rec (1998) 0.93
Behavior of serum in the borate modification of the carbazole reaction. Anal Biochem (1969) 0.93
Hepatotoxicity of tetrahydroaminoacridine. Lancet (1988) 0.93
Fractionation and recovery of secretions of synovial cells synthesized in culture with radioactive precursors. Ann Rheum Dis (1973) 0.93
Relationship between chromosomal changes and alterations in the behaviour of a strain of human synovial cells during its life history in vitro. Ann Rheum Dis (1968) 0.93
Barrier around synovial cells in vitro. Nature (1967) 0.93
Rubella arthritis in adults. Isolation of virus, cytology and other aspects of the synovial reaction. Clin Exp Rheumatol (1985) 0.93
The catabolic fate of hyaluronic acid. Connect Tissue Res (1986) 0.91
Apoptosis and dendritic dysfunction precede prion protein accumulation in 87V scrapie. Neuroreport (2001) 0.91
Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features. Ann Rheum Dis (1992) 0.91
Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology (1992) 0.91
Early loss of dendritic spines in murine scrapie revealed by confocal analysis. Neuroreport (2001) 0.91
Articular cartilage in rheumatoid arthritis: ultrastructure and enzymology. J Rheumatol (1974) 0.91
The exanthem of Ross River virus infection: histology, location of virus antigen and nature of inflammatory infiltrate. J Clin Pathol (1983) 0.91
Catabolism of hyaluronan in the knee joint of the rabbit. Matrix (1992) 0.91
Dendritic and synaptic alterations of hippocampal pyramidal neurones in scrapie-infected mice. Neuropathol Appl Neurobiol (2000) 0.90
Comparison of effectiveness of mefenamic acid and ibuprofen in treatment of rheumatoid arthritis. Med J Aust (1976) 0.90
Heterogeneity of adverse hepatic reactions to tetrahydroaminoacridine. Aust N Z J Med (1990) 0.90
Serum hyaluronan as a disease marker. Ann Med (1996) 0.90
A new disorder of hyaluronan metabolism associated with generalized folding and thickening of the skin. J Pediatr (2000) 0.89
Enzymic pathways of hyaluronan catabolism. Ciba Found Symp (1989) 0.89
Observations on rheumatic disease in Polynesia and the Philippines. J Rheumatol Suppl (1983) 0.89
Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunocytochemistry. Neuropathol Appl Neurobiol (1995) 0.88
Extraction and measurement of glycosaminoglycans in serum and cell culture medium: a system with the use of an aliphatic quaternary ammonium salt. J Lab Clin Med (1969) 0.88
Specificity of antibodies to type II collagen in early rheumatoid arthritis. J Rheumatol (1994) 0.88
Some factors influencing the reactions of human synovial cells in vitro with fresh homologous and autologous serum. Aust J Exp Biol Med Sci (1968) 0.88
Specific and non-specific immunological changes in epidemic polyarthritis patients. Aust J Exp Biol Med Sci (1981) 0.88
Case study: World Health Organization-International League of Associations for Rheumatology Community-Oriented Programme for the Control of Rheumatic Diseases (WHO-ILAR COPCORD) in Indonesia and Brazil. Int J Technol Assess Health Care (1995) 0.87
The prevalence of soft tissue rheumatism. A who-ilar copcord study. Rheumatol Int (1995) 0.87
Inhibition of hyaluronan uptake in lymphatic tissue by chondroitin sulphate proteoglycan. Biochem J (1989) 0.87
Synaptic plasticity in the CA1 area of the hippocampus of scrapie-infected mice. Neurobiol Dis (1998) 0.87
Mononuclear cell types in chronic synovial effusions of Ross River virus disease. Aust N Z J Med (1984) 0.86
Detection of Ross River virus immunoglobulin M antibodies by enzyme-linked immunosorbent assay using antibody class capture and comparison with other methods. Pathology (1985) 0.86
Quantitation of hyaluronic acid in equine synovia. Am J Vet Res (1982) 0.86
Lyme disease challenges Australian clinicians: the implications of Australia's first reported case of Lyme arthritis. Med J Aust (1982) 0.86
Rheumatic disease in a Philippine village. II: a WHO-ILAR-APLAR COPCORD study, phases II and III. Rheumatol Int (1991) 0.86
Surgical treatment of aortic valvular disease in rheumatoid arthritis. Med J Aust (1975) 0.85
Clearnace of Fe59-labelled erythrocytes from normal and inflamed rabbit knee joints. I. Relationship to the anaemia of rheumatoid arthritis. Ann Rheum Dis (1969) 0.85